Related references
Note: Only part of the references are listed.Adaptive enrichment trials: What are the benefits?
Thomas Burnett et al.
STATISTICS IN MEDICINE (2021)
Optimal, two-stage, adaptive enrichment designs for randomized trials, using sparse linear programming
Michael Rosenblum et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2020)
Improving interim decisions in randomized trials by exploiting information on short-term endpoints and prognostic baseline covariates
Kelly Van Lancker et al.
PHARMACEUTICAL STATISTICS (2020)
Adaptive enrichment designs for confirmatory trials
Tze Leung Lai et al.
STATISTICS IN MEDICINE (2019)
Adaptive design clinical trials: a review of the literature and ClinicalTrials.gov
Laura E. Bothwell et al.
BMJ OPEN (2018)
A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines
Pankaj Mistry et al.
BMC MEDICAL RESEARCH METHODOLOGY (2017)
Group sequential designs with prospectively planned rules for subpopulation enrichment
Michael Rosenblum et al.
STATISTICS IN MEDICINE (2016)
Adaptive choice of patient subgroup for comparing two treatments
Tze Leung Lai et al.
CONTEMPORARY CLINICAL TRIALS (2014)
Group sequential tests for delayed responses
Lisa V. Hampson et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2013)
An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints
Martin Jenkins et al.
PHARMACEUTICAL STATISTICS (2011)
THE SEQUENTIAL REJECTION PRINCIPLE OF FAMILYWISE ERROR CONTROL
Jelle J. Goeman et al.
ANNALS OF STATISTICS (2010)
A confirmatory seamless phase II/III clinical trial design incorporating short-term endpoint information
Nigel Stallard
STATISTICS IN MEDICINE (2010)